JP2010520166A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520166A5
JP2010520166A5 JP2009551194A JP2009551194A JP2010520166A5 JP 2010520166 A5 JP2010520166 A5 JP 2010520166A5 JP 2009551194 A JP2009551194 A JP 2009551194A JP 2009551194 A JP2009551194 A JP 2009551194A JP 2010520166 A5 JP2010520166 A5 JP 2010520166A5
Authority
JP
Japan
Prior art keywords
compound
acid
group
mucosa
aminophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009551194A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520166A (ja
JP5351772B2 (ja
Filing date
Publication date
Priority claimed from IE20070129A external-priority patent/IE20070129A1/en
Application filed filed Critical
Publication of JP2010520166A publication Critical patent/JP2010520166A/ja
Publication of JP2010520166A5 publication Critical patent/JP2010520166A5/ja
Application granted granted Critical
Publication of JP5351772B2 publication Critical patent/JP5351772B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009551194A 2007-02-28 2008-02-27 免疫保護性刺激物質としてカチオン性抗菌ペプチド発現を誘導するためのＰＰＡＲ−γアゴニスト Expired - Fee Related JP5351772B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE2007/0129 2007-02-28
IE20070129A IE20070129A1 (en) 2007-02-28 2007-02-28 Ppar-gamma agonists stimulate enteric defensin expression
PCT/EP2008/052354 WO2008104557A1 (en) 2007-02-28 2008-02-27 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants

Publications (3)

Publication Number Publication Date
JP2010520166A JP2010520166A (ja) 2010-06-10
JP2010520166A5 true JP2010520166A5 (https=) 2010-11-25
JP5351772B2 JP5351772B2 (ja) 2013-11-27

Family

ID=39358381

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551194A Expired - Fee Related JP5351772B2 (ja) 2007-02-28 2008-02-27 免疫保護性刺激物質としてカチオン性抗菌ペプチド発現を誘導するためのＰＰＡＲ−γアゴニスト

Country Status (19)

Country Link
US (1) US20110152225A1 (https=)
EP (1) EP2131829B1 (https=)
JP (1) JP5351772B2 (https=)
AR (1) AR065525A1 (https=)
AT (1) ATE553759T1 (https=)
AU (1) AU2008220762B2 (https=)
BR (1) BRPI0807377A8 (https=)
CA (1) CA2678159C (https=)
CY (1) CY1113000T1 (https=)
DK (1) DK2131829T3 (https=)
ES (1) ES2384195T3 (https=)
HR (1) HRP20120473T1 (https=)
IE (1) IE20070129A1 (https=)
MX (1) MX2009009006A (https=)
PL (1) PL2131829T3 (https=)
PT (1) PT2131829E (https=)
RS (1) RS52251B (https=)
SI (1) SI2131829T1 (https=)
WO (1) WO2008104557A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
ITRM20050390A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
GB0821687D0 (en) * 2008-11-28 2008-12-31 Secr Defence Peptides
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
SI2805746T1 (sl) 2009-02-16 2020-10-30 Nogra Pharma Limited Alkilamido spojine in njihova uporaba
RU2013114390A (ru) 2010-08-31 2014-10-10 СНУ Ар энд ДиБи ФАУНДЕЙШН Применение фетального репрограммирования посредством ppar-дельта-агониста
CA2864059C (en) 2012-02-09 2020-04-28 Nogra Pharma Limited Methods of treating fibrosis
MX2014012652A (es) * 2012-04-18 2014-11-25 Nogra Pharma Ltd Metodo de tratamiento de la intolerancia a la lactosa.
EP3419616A1 (en) * 2016-02-26 2019-01-02 Nogra Pharma Limited Methods of treating lactose intolerance
US11690824B2 (en) * 2018-04-10 2023-07-04 The General Hospital Corporation Antibacterial compounds
EP4495101A3 (en) 2019-02-08 2025-04-30 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN116548385B (zh) * 2023-04-20 2023-10-27 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 自发型系统性红斑狼疮动物模型的构建方法及应用
CN120209086B (zh) * 2024-11-08 2026-04-07 中国海洋大学 一种抗菌肽及其在溃疡性结肠炎治疗中的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US466012A (en) * 1891-12-29 Manufacture of posts
US1179533A (en) * 1910-04-20 1916-04-18 Maurice Lachman Pole.
US1034760A (en) * 1912-02-14 1912-08-06 Friedrich Georg Franz Braeckerbohm Mast for radiotelegraphy.
US1200453A (en) * 1915-12-22 1916-10-10 Bates Expanded Steel Truss Co Metallic pole.
US1616931A (en) * 1925-10-10 1927-02-08 Percy H Thomas Transmission tower for electric circuits
US2064121A (en) * 1933-10-23 1936-12-15 Lapp Insulator Company Inc Insulator for radio masts
US2116368A (en) * 1936-07-21 1938-05-03 Blaw Knox Co Antenna tower
US2401799A (en) * 1941-08-04 1946-06-11 Union Metal Mfg Co Radio antenna tower
US2410246A (en) * 1943-04-17 1946-10-29 Masts Ltd Mast, pole, and the like
US3196990A (en) * 1961-03-23 1965-07-27 Mc Graw Edison Co Tapered structural member and method of making the same
US3343315A (en) * 1964-08-04 1967-09-26 Aluminium Lab Ltd Guyed y tower
US3504464A (en) * 1966-03-07 1970-04-07 Kaiser Aluminium Chem Corp Tower structure and method of erecting the same
US3571991A (en) * 1969-02-06 1971-03-23 Anderson Electric Corp Metal pole
JPS4860435A (https=) * 1971-11-30 1973-08-24
US3935689A (en) * 1974-04-01 1976-02-03 Contran Corporation Transmission line structure
US4314434A (en) * 1977-07-07 1982-02-09 Meisberger Raymond F Utility line support structure
US4431375A (en) * 1979-05-10 1984-02-14 Carter Wind Power Wind-driven generator apparatus
US5319901A (en) * 1991-06-14 1994-06-14 Goldsworthy W Brandt Bifurcated column joint system for electrical transmission tower
AU1388388A (en) * 1987-04-01 1988-10-06 Dak-Laboratoriet A/S Benzoic acid derivatives and use thereof
EP0352826B1 (en) * 1988-05-05 1994-10-26 Tillotts Pharma Ag Use of 5-aminosalicylic acid in the treatment of dermatological disorders
US6286281B1 (en) * 1991-06-14 2001-09-11 David W. Johnson Tubular tapered composite pole for supporting utility lines
US5687537A (en) * 1996-05-24 1997-11-18 Pi Rod Inc. Modular antenna pole
US5880404A (en) * 1996-06-28 1999-03-09 Advanced Metals Technology Corporation Power transmission support structures
GB9617001D0 (en) * 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
US6343445B1 (en) * 2000-03-07 2002-02-05 General Signal Corporation Tower structure
WO2002018324A2 (en) * 2000-08-29 2002-03-07 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
US6668498B2 (en) * 2000-12-13 2003-12-30 Ritz Telecommunications, Inc. System and method for supporting guyed towers having increased load capacity and stability
JP2003095938A (ja) * 2001-09-21 2003-04-03 Masami Moriyama 抗菌ペプチド分泌誘発剤
JP2004107302A (ja) * 2002-09-20 2004-04-08 Masami Moriyama 過敏性腸症候群治療薬
US7059095B1 (en) * 2002-10-11 2006-06-13 Stevens James A Anchored monopole upgrade system
US7119079B2 (en) * 2003-01-22 2006-10-10 Barbeau Donald L Bioadhesive pharmaceutical compositions
GB0303609D0 (en) * 2003-02-17 2003-03-19 Glaxo Group Ltd Novel therapeutic method and compositions
US6952058B2 (en) * 2003-02-20 2005-10-04 Wecs, Inc. Wind energy conversion system
CA2424599A1 (en) * 2003-04-04 2004-10-04 Andre Rioux Modular tower structure
US7592300B2 (en) * 2003-11-24 2009-09-22 The Dial Corporation Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.

Similar Documents

Publication Publication Date Title
JP2010520166A5 (https=)
JP5714512B2 (ja) 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物
JP2012522037A5 (https=)
TW202126313A (zh) 安定之普維酮—碘組成物
JP2017503852A5 (https=)
Jácomo et al. Effect of oral hygiene with 0.12% chlorhexidine gluconate on the incidence of nosocomial pneumonia in children undergoing cardiac surgery
CA2691446A1 (en) Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses
CA2682494A1 (en) Hexahydro-1h-4,7-methanoisoindole-1,3-dione compounds for treating psychiatric disorders
Zhao et al. Ultra-slippery, nonirritating, and anti-inflammatory hyaluronic acid-based coating to mitigate intubation injury
TW201940180A (zh) 治療慢性發炎疾病的方法
JP2005535578A (ja) トルテロジン塩
JPWO2020112542A5 (https=)
JP2006514665A5 (https=)
ATE410163T1 (de) Verfahren zur behandlung und diagnose von atemstörungen im schlaf mit zonisamid und mittel zur durchführung des verfahrens
TW200901957A (en) N-halogenated amino acid formulations with anti-inflammatory compounds
JP6153264B2 (ja) 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
JP2024536583A (ja) 自閉症スペクトラム障害の治療におけるエダラボンの使用
JP5997658B2 (ja) 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用
WO2014155074A1 (en) Composition
TW202227080A (zh) 帕金森氏症之運動併發症治療藥
US20250213542A1 (en) Devices and methods for delivering synergistic active agents to target sites
CN116059327B (zh) 一种溶菌酶鼻腔喷雾剂及其制备方法
JP2010111667A (ja) フェキソフェナジン又はエバスチンを含有する鎮咳及び／又は去痰のための医薬組成物
Madana et al. Laryngotracheal rhinosporidiosis
JP2017105853A (ja) 非常に速い皮膚及び膜浸透速度を有するｎｓａｉａプロドラッグ及びその新規医薬使用